Anastasia A, Dellavedova G, Ramos-Montoya A et al (2022) The DNA-PK inhibitor AZD7648 sensitizes patient-derived ovarian Cancer xenografts to Pegylated Liposomal Doxorubicin and Olaparib preventing abdominal metastases. Mol Cancer Ther 21:555–567
Biswas S, Mandal G, Payne KK et al (2021) IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature 591(7850):464–470
Article PubMed PubMed Central Google Scholar
Cai J, Gong L, Li G et al (2021) Exosomes in ovarian cancer ascites promote epithelial–mesenchymal transition of ovarian cancer cells by delivery of miR-6780b-5p. Cell Death Dis 12:210
Article PubMed PubMed Central Google Scholar
Gao Y, Meng H, Liu S et al (2015) LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b. Hum Mol Genet 24:841–852
Jiang W, Pan S, Chen X et al (2021) The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy. Mol Cancer 20:116
Article PubMed PubMed Central Google Scholar
Kurnit KC, Fleming GF, Lengyel E (2021) Updates and new options in advanced epithelial ovarian Cancer treatment. Obstet Gynecol 137:108–121
Li F, Ren Y, Wang Z (2018) Programmed death 1 ligand 1 expression in breast cancer and its association with patients’ clinical parameters. J Cancer Res Ther 14:150–154
Li D, Hong X, Zhao F et al (2021) Targeting Nrf2 may reverse the drug resistance in ovarian cancer. Cancer Cell Int 21:116
Article PubMed PubMed Central Google Scholar
Liu M, Yang F, Ma L (2021) Antiproliferative effect of cryptotanshinone against human non-small cell lung cancer cells through inactivation of lncRNA HOTAIR/p-Akt signaling pathway. Arab J Chem 14:103150
Pignata S, Scambia G, Villanucci A et al (2021) A European, observational, Prospective Trial of Trabectedin plus Pegylated Liposomal Doxorubicin in patients with platinum-sensitive ovarian Cancer. Oncologist 26:e658–e668
Article PubMed PubMed Central Google Scholar
Shen Y, Lv M, Fang Y et al (2021) LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis. J Ovarian Res 14:161
Article PubMed PubMed Central Google Scholar
Song K, Yuan X, Li G et al (2019) Long noncoding RNA CASC11 promotes osteosarcoma metastasis by suppressing degradation of snail mRNA. Am J Cancer Res 9:300–311
PubMed PubMed Central Google Scholar
Swisher EM, Kwan TT, Oza AM et al (2021) Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (parts 1 and 2). Nat Commun 12:2487
Article PubMed PubMed Central Google Scholar
Wan SQ, Liu JD, Chen JQ (2021) Expression and significance of long noncoding RNA tumor susceptibility candidate gene 11 in ovarian cancer tissues. J Practical Clin Med 25:114–118123
Wang C, Wang J, Shen X et al (2021) LncRNA SPOCD1-AS from ovarian cancer extracellular vesicles remodels mesothelial cells to promote peritoneal metastasis via interacting with G3BP1. J Exp Clin Cancer Res 40:101
Article PubMed PubMed Central Google Scholar
Wojtowicz K, Sterzyńska K, Świerczewska M et al (2021) Piperine targets different drug resistance mechanisms in human ovarian cancer cell lines leading to increased sensitivity to cytotoxic drugs. Int J Mol Sci 22:4243
Article PubMed PubMed Central Google Scholar
Ye Y, Dai Q, Qi H (2021) A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer. Cell Death Discov 7:71
Article PubMed PubMed Central Google Scholar
Zhang Z, Zhou C, Chang Y et al (2016) Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer. Cancer Lett 376:62–73
Zhang Z, Zhu H, Hu J (2021) CircRAB11FIP1 promoted autophagy flux of ovarian cancer through DSC1 and miR-129. Cell Death Dis 12:219
Article PubMed PubMed Central Google Scholar
Zheng L, Guan Z, Xue M (2021) A crucial role for the long non-coding RNA CASC11 in the pathogenesis of human cancers. Am J Transl Res 13:10922–10932
留言 (0)